BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest 8-K15D5 SEC Filings
Notification of assumption of duty to report by successor issue [Section 15(d)]

SOMATIX THERAPY CORPORATION, 8-K15D5, 1995-09-20


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission